Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0; removed the prior v3.1.0 reference.SummaryDifference9%

- Check32 days agoChange DetectedPage now shows v3.1.0 with new Study Status Contacts/Locations (dated 2025-09-19 and 2025-09-22) replacing the prior v3.0.2 from 2025-06-24.SummaryDifference1%

- Check46 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.5%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%

- Check61 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference60%

- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.